These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18024322)

  • 1. VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Gianelli U; Vener C; Raviele PR; Savi F; Somalvico F; Calori R; Iurlo A; Radaelli F; Fermo E; Bucciarelli P; Bori S; Coggi G; Deliliers GL
    Am J Clin Pathol; 2007 Dec; 128(6):966-73. PubMed ID: 18024322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.
    Boiocchi L; Vener C; Savi F; Bonoldi E; Moro A; Fracchiolla NS; Iurlo A; Deliliers GL; Coggi G; Bosari S; Gianelli U
    J Clin Pathol; 2011 Mar; 64(3):226-31. PubMed ID: 21217153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
    Boveri E; Passamonti F; Rumi E; Pietra D; Elena C; Arcaini L; Pascutto C; Castello A; Cazzola M; Magrini U; Lazzarino M
    Br J Haematol; 2008 Jan; 140(2):162-8. PubMed ID: 18028479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
    Medinger M; Skoda R; Gratwohl A; Theocharides A; Buser A; Heim D; Dirnhofer S; Tichelli A; Tzankov A
    Br J Haematol; 2009 Jul; 146(2):150-7. PubMed ID: 19466975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia].
    Zhang L; Wang HJ; Li HQ; Yang DL; Yan ZS; Wu YH; Zhou K; Chu YL; Chen HS; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):528-31. PubMed ID: 18078128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.
    Bock O; Tessema M; Serinsöz E; von Wasielewski R; Büsche G; Kreipe H
    Leuk Res; 2004 Nov; 28(11):1145-51. PubMed ID: 15380337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
    Florena AM; Tripodo C; Iannitto E; Porcasi R; Ingrao S; Franco V
    Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
    Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
    Rudzki Z; Papla B; Stachura J
    Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
    Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
    Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.
    Steurer M; Zoller H; Augustin F; Fong D; Heiss S; Strasser-Weippl K; Gastl G; Tzankov A
    Hum Pathol; 2007 Jul; 38(7):1057-1064. PubMed ID: 17442379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations.
    Kiuchi H; Tsujimura A; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Nonomura N; Takeyama M; Okuyama A
    BJU Int; 2009 Sep; 104(6):826-31; discussion 831. PubMed ID: 19298410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma.
    Möbius C; Demuth C; Aigner T; Wiedmann M; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Eur J Surg Oncol; 2007 Oct; 33(8):1025-9. PubMed ID: 17400419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.